Karen H Antman

Ontology type: schema:Person     

Person Info


Karen H



Publications in SciGraph latest 50 shown

  • 2007-09 A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study in BMC MEDICAL GENETICS
  • 2005 Malignant Mesothelioma Following Radiation in MALIGNANT MESOTHELIOMA
  • 2002-10 Reducing Disparities in Breast Cancer Survival: A Columbia University and Avon Breast Cancer Research and Care Network Symposium* in BREAST CANCER RESEARCH AND TREATMENT
  • 2002-08 Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer in BONE MARROW TRANSPLANTATION
  • 2000 Phase 1 Trial of Retroviral-Mediated Transfer of the Human MDR-1 in Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation in CELL THERAPY
  • 1999-09 A Phase I Study of High-dose BCNU, Etoposide and Escalating-dose Thiotepa (BTE) with Hematopoietic Progenitor Cell Support in Adults with Recurrent and High-risk Brain Tumors in JOURNAL OF NEURO-ONCOLOGY
  • 1995-07 High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1994-01 Phase IV trial of daily oral etoposide in the treatment of advanced soft-tissue sarcoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1991-07 Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 1991-05 Phase II trial of trimetrexate in patients with advanced soft-tissue sarcoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1991-01 A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1989-01 Diverse prognosis in metastatic breast cancer: Who should be offered alternative initial therapies? in BREAST CANCER RESEARCH AND TREATMENT
  • 1988 Chemotherapy of Advanced Soft Tissue Sarcomas in RECENT CONCEPTS IN SARCOMA TREATMENT
  • 1984 A Phase I Trial of Intracavitary Doxorubicin (Adriamycin) Alternating with Cisplatin in INTRA-ARTERIAL AND INTRACAVITARY CANCER CHEMOTHERAPY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.475010.7", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "https://www.grid.ac/institutes/grid.239585.0", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.21729.3f", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.189504.1", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.413734.6", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
        "familyName": "Antman", 
        "givenName": "Karen H", 
        "id": "sg:person.07422224577.84", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T13:34", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_1358.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.07422224577.84'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.07422224577.84'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.07422224577.84'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.07422224577.84'


    This table displays all metadata directly associated to this object as RDF triples.

    28 TRIPLES      10 PREDICATES      17 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.07422224577.84 schema:affiliation N3e949ce8dc4c419ba751ecf46684208c
    2 https://www.grid.ac/institutes/grid.189504.1
    3 https://www.grid.ac/institutes/grid.21729.3f
    4 https://www.grid.ac/institutes/grid.239585.0
    5 https://www.grid.ac/institutes/grid.38142.3c
    6 https://www.grid.ac/institutes/grid.413734.6
    7 https://www.grid.ac/institutes/grid.65499.37
    8 schema:familyName Antman
    9 schema:givenName Karen H
    10 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07422224577.84
    11 schema:sdDatePublished 2019-03-07T13:34
    12 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    13 schema:sdPublisher N41d62844b43a4ec3a61be0d0a872a1d0
    14 sgo:license sg:explorer/license/
    15 sgo:sdDataset persons
    16 rdf:type schema:Person
    17 N3e949ce8dc4c419ba751ecf46684208c schema:affiliation https://www.grid.ac/institutes/grid.475010.7
    18 sgo:isCurrent true
    19 rdf:type schema:OrganizationRole
    20 N41d62844b43a4ec3a61be0d0a872a1d0 schema:name Springer Nature - SN SciGraph project
    21 rdf:type schema:Organization
    22 https://www.grid.ac/institutes/grid.189504.1 schema:Organization
    23 https://www.grid.ac/institutes/grid.21729.3f schema:Organization
    24 https://www.grid.ac/institutes/grid.239585.0 schema:Organization
    25 https://www.grid.ac/institutes/grid.38142.3c schema:Organization
    26 https://www.grid.ac/institutes/grid.413734.6 schema:Organization
    27 https://www.grid.ac/institutes/grid.475010.7 schema:Organization
    28 https://www.grid.ac/institutes/grid.65499.37 schema:Organization

    Preview window. Press ESC to close (or click here)